Romm Preston S 4
4 · Obagi Medical Products, Inc. · Filed Nov 18, 2011
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2011-11-16$9.92/sh−1,300$12,898→ 0 total - Exercise/Conversion
Common Stock
2011-11-18$5.86/sh+13,179$77,229→ 13,179 total - Sale
Common Stock
2011-11-16$9.97/sh−8,286$82,607→ 1,300 total - Exercise/Conversion
Common Stock
2011-11-17$5.86/sh+10,569$61,934→ 10,569 total - Sale
Common Stock
2011-11-17$9.67/sh−4,369$42,251→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2011-11-16−9,586→ 40,414 totalExercise: $5.86Exp: 2019-03-03→ Common Stock (9,586 underlying) - Sale
Common Stock
2011-11-17$9.95/sh−5,600$55,720→ 4,969 total - Exercise/Conversion
Common Stock
2011-11-16$5.86/sh+9,586$56,174→ 9,586 total - Sale
Common Stock
2011-11-17$9.78/sh−600$5,870→ 4,369 total - Sale
Common Stock
2011-11-18$9.72/sh−13,179$128,056→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2011-11-17−10,569→ 29,845 totalExercise: $5.86Exp: 2019-03-03→ Common Stock (10,569 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2011-11-18−13,179→ 16,666 totalExercise: $5.86Exp: 2019-03-03→ Common Stock (13,179 underlying)
Footnotes (1)
- [F1]Fully vested and immediately exercisable.